tiprankstipranks
Trending News
More News >
Elixirr International Plc (GB:ELIX)
LSE:ELIX

Elixirr International Plc (ELIX) AI Stock Analysis

Compare
20 Followers

Top Page

GB

Elixirr International Plc

(LSE:ELIX)

Rating:80Outperform
Price Target:
902.00p
▲(18.68%Upside)
Elixirr International Plc is a well-managed company with strong financial fundamentals and a fair valuation. The company's robust financial performance is a key strength, supported by effective cash flow management and a strong balance sheet. The technical analysis presents mixed signals, but the valuation suggests reasonable pricing. Strategic corporate events further bolster the company's growth outlook.
Positive Factors
Financial Performance
Elixirr's strong financial track record continued with revenues up 30% and an adjusted EBITDA margin of 28%.
Growth Strategy
Continued execution of its four-pillar strategy supports revenue growth, including expanding service offerings and successful acquisitions like Hypothesis.
Market Expansion
Plans to move to the LSE Main Market should enhance the investor base and company's profile, with potential inclusion in the FTSE 250.
Negative Factors
Market Expectations
FY24E results are expected to be above market expectations, with revenue greater than £111m.

Elixirr International Plc (ELIX) vs. iShares MSCI United Kingdom ETF (EWC)

Elixirr International Plc Business Overview & Revenue Model

Company DescriptionElixirr International plc, through its subsidiaries, provides management consultancy services in the United Kingdom, the United States, and internationally. It offers creative, marketing, and self-funded transformation services. The company offers its services for various industries, such as automotive and transportation, manufacturing, business and financial services, charities, energy, utilities and resources, healthcare and pharmaceuticals, insurance, luxury and fashion, travel and leisure, telecommunications, technology, retail and consumer goods, private equity, media, and entertainment and sports industries. Elixirr International plc was founded in 2009 and is headquartered in London, the United Kingdom.
How the Company Makes MoneyElixirr International Plc makes money primarily through providing consulting services to its clients. The company's revenue model is based on fees charged for its expert advisory services, which are typically billed on a time-and-materials basis or through fixed-price contracts. Key revenue streams include strategic consulting projects, digital transformation initiatives, and technology implementation services. Elixirr also benefits from long-term client relationships and repeat business, which contribute significantly to its earnings. Additionally, the company's global reach and expertise across various sectors enable it to secure partnerships and collaborations that enhance its service offerings and revenue potential.

Elixirr International Plc Financial Statement Overview

Summary
Elixirr International Plc demonstrates strong financial performance with robust revenue growth, efficient operations, and solid cash flow management. The company maintains a strong balance sheet with low leverage and high equity, providing financial stability and flexibility.
Income Statement
89
Very Positive
Elixirr International Plc has demonstrated robust growth in revenue with a year-over-year increase from 2023 to 2024. The company maintains strong profitability, evidenced by a healthy gross profit margin and net profit margin. The EBIT and EBITDA margins indicate efficient operational management. Overall, the income statement reflects a solid and growing company with strong financial performance.
Balance Sheet
85
Very Positive
The company's balance sheet is strong, with a low debt-to-equity ratio, reflecting prudent financial management. The equity ratio is high, indicating a stable capital structure with significant stockholders' equity relative to total assets. Return on equity remains attractive, showcasing the company's ability to generate returns for shareholders. The company's financial stability is underscored by its solid asset base and manageable liabilities.
Cash Flow
87
Very Positive
Elixirr International Plc exhibits impressive cash flow management, highlighted by substantial free cash flow growth. The operating cash flow to net income ratio is strong, indicating efficient conversion of income into cash. Free cash flow to net income is well-aligned, signaling effective reinvestment and financial strategy. The cash flow statements reflect a healthy liquidity position and sound financial practices.
Breakdown
Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income StatementTotal Revenue
111.34M85.89M70.70M50.61M30.32M
Gross Profit
35.81M29.26M23.16M17.70M11.19M
EBIT
24.57M22.62M16.90M12.38M6.48M
EBITDA
27.96M25.78M20.02M14.46M8.97M
Net Income Common Stockholders
16.38M17.24M12.87M10.14M4.79M
Balance SheetCash, Cash Equivalents and Short-Term Investments
7.53M18.13M20.43M31.80M17.50M
Total Assets
175.89M154.40M128.66M107.17M87.00M
Total Debt
4.90M5.36M5.14M5.25M5.29M
Net Debt
-2.63M-12.77M-15.29M-26.55M-12.22M
Total Liabilities
43.78M34.84M32.74M21.13M16.31M
Stockholders Equity
132.11M119.56M95.92M86.04M70.69M
Cash FlowFree Cash Flow
28.76M16.67M15.40M14.23M12.12M
Operating Cash Flow
28.84M16.79M15.73M14.33M12.15M
Investing Cash Flow
-21.50M-14.82M-18.53M-3.24M-1.46M
Financing Cash Flow
-17.64M-4.06M-8.85M3.11M3.88M

Elixirr International Plc Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price760.00
Price Trends
50DMA
728.50
Positive
100DMA
748.94
Positive
200DMA
721.70
Positive
Market Momentum
MACD
2.66
Positive
RSI
44.77
Neutral
STOCH
43.05
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For GB:ELIX, the sentiment is Neutral. The current price of 760 is below the 20-day moving average (MA) of 799.50, above the 50-day MA of 728.50, and above the 200-day MA of 721.70, indicating a neutral trend. The MACD of 2.66 indicates Positive momentum. The RSI at 44.77 is Neutral, neither overbought nor oversold. The STOCH value of 43.05 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for GB:ELIX.

Elixirr International Plc Peers Comparison

Overall Rating
UnderperformOutperform
Sector (66)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
80
Outperform
£360.26M21.7213.02%1.67%29.64%-7.27%
77
Outperform
£401.53M10.2035.97%4.14%22.39%179.53%
77
Outperform
£286.53M48.505.78%0.89%20.65%-17.11%
GBWIL
73
Outperform
£309.03M8.4614.26%3.26%-8.18%90.18%
66
Neutral
$4.51B12.295.40%3.67%4.15%-12.21%
64
Neutral
£1.35B46.0012.82%1.16%4.54%-2.11%
GBRWA
56
Neutral
£145.16M29.69-3.96%16.04%-16.16%-145.46%
* Industrials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
GB:ELIX
Elixirr International Plc
760.00
194.67
34.43%
GB:GFRD
Galliford Try
411.00
190.16
86.11%
GB:DATA
GlobalData
155.00
-70.99
-31.41%
GB:RWA
Robert Walters
213.00
-172.88
-44.80%
GB:WIL
Wilmington
350.00
-14.31
-3.93%
GB:FNTL
Fintel PLC
269.00
-28.95
-9.72%

Elixirr International Plc Corporate Events

Executive/Board ChangesBusiness Operations and Strategy
Elixirr International Grants Share Options to Key Executives
Positive
Jun 10, 2025

Elixirr International plc has announced the grant of share options to key managerial figures, Clare Filby and Christopher Jordan, as part of its unapproved share option plan. These options, which cover a total of 119,048 ordinary shares each, represent approximately 0.49% of the company’s issued share capital and are set at an exercise price of 840p per share with a five-year vesting period. This move is indicative of Elixirr’s strategy to incentivize its leadership team, potentially enhancing its market position and aligning managerial interests with shareholder value.

The most recent analyst rating on (GB:ELIX) stock is a Buy with a £850.00 price target. To see the full list of analyst forecasts on Elixirr International Plc stock, see the GB:ELIX Stock Forecast page.

Delistings and Listing ChangesBusiness Operations and Strategy
Elixirr International to Transition to Main Market, Enhancing Growth Strategy
Positive
May 30, 2025

Elixirr International plc has announced its plans to transition from the AIM to the Main Market of the London Stock Exchange, a move reflecting its growth and ambition. The transition is expected to complete by July 1, 2025, and aims to enhance Elixirr’s market positioning, with the existing AIM listing being canceled. This strategic shift is part of Elixirr’s broader growth strategy, which will be further discussed during their Capital Markets Day event, showcasing their innovative solutions and partnerships.

The most recent analyst rating on (GB:ELIX) stock is a Buy with a £850.00 price target. To see the full list of analyst forecasts on Elixirr International Plc stock, see the GB:ELIX Stock Forecast page.

M&A TransactionsBusiness Operations and Strategy
Elixirr International Announces Share Transactions and Adjustments
Neutral
May 29, 2025

Elixirr International plc announced recent transactions involving its ordinary shares, including the transfer of shares to former shareholders of acquired businesses and a sale by its Non-Executive Chairman. These transactions reflect ongoing adjustments in the company’s shareholding structure, potentially impacting its market positioning and stakeholder interests.

The most recent analyst rating on (GB:ELIX) stock is a Buy with a £850.00 price target. To see the full list of analyst forecasts on Elixirr International Plc stock, see the GB:ELIX Stock Forecast page.

Shareholder MeetingsDividendsFinancial Disclosures
Elixirr International Announces 2024 Annual Report and Dividend Timetable
Positive
May 29, 2025

Elixirr International plc has announced the posting of its 2024 Annual Report and AGM notice, along with the final dividend timetable for the year ended 31 December 2024. The AGM is scheduled for 24 June 2025, and the final dividend of 11.5p per share will be paid on 20 August 2025. This announcement underscores Elixirr’s commitment to transparency and shareholder engagement, potentially strengthening its market position and stakeholder relations.

The most recent analyst rating on (GB:ELIX) stock is a Buy with a £850.00 price target. To see the full list of analyst forecasts on Elixirr International Plc stock, see the GB:ELIX Stock Forecast page.

Business Operations and Strategy
Elixirr International to Host Capital Markets Day Highlighting Growth Strategy
Positive
May 21, 2025

Elixirr International plc is set to host a Capital Markets Day on June 4, 2025, at its London office, inviting institutional investors and analysts to gain insights into its growth strategy and future plans. The event will feature interactive sessions led by global partners, showcasing Elixirr’s innovative digital, data, tech, and AI solutions, including collaborations with Meta and British Cycling, highlighting the company’s commitment to transforming customer experiences and advancing its industry positioning.

The most recent analyst rating on (GB:ELIX) stock is a Buy with a £850.00 price target. To see the full list of analyst forecasts on Elixirr International Plc stock, see the GB:ELIX Stock Forecast page.

Business Operations and Strategy
Elixirr International to Host Capital Markets Day on June 4, 2025
Positive
May 21, 2025

Elixirr International plc is set to host a Capital Markets Day on June 4, 2025, at its London office, inviting institutional investors and analysts to gain insights into its growth strategy and future plans. The event will feature interactive sessions with global partners, showcasing Elixirr’s advanced digital, data, tech, and AI solutions, including collaborations with major clients like Meta and British Cycling, highlighting the company’s innovative approach and industry impact.

The most recent analyst rating on (GB:ELIX) stock is a Buy with a £850.00 price target. To see the full list of analyst forecasts on Elixirr International Plc stock, see the GB:ELIX Stock Forecast page.

Stock BuybackBusiness Operations and Strategy
Elixirr Strengthens Market Position with Strategic Share Acquisition
Positive
May 8, 2025

Elixirr International plc has announced that its Employee Benefit Trust has purchased 308,786 ordinary shares at 780p per share, now holding 3.29% of the company’s issued share capital. This strategic move, guided by Apex Group Fiduciary Services Limited, aims to ensure sufficient shares for employee incentives and new partners, supporting the company’s growth strategy without diluting equity, thereby strengthening its market position.

Delistings and Listing ChangesBusiness Operations and StrategyFinancial Disclosures
Elixirr Reports Record FY 2024 Results and Plans Main Market Move
Positive
Apr 28, 2025

Elixirr International Plc reported a record financial performance for the fiscal year 2024, driven by strong client demand and geographic expansion, with a 30% increase in revenue to £111.3 million. The company plans to move to the Main Market of the London Stock Exchange, which is expected to enhance access to institutional capital and support long-term growth. This strategic move follows significant growth since 2019, including revenue and EBITDA quadrupling and several acquisitions. The company remains confident in its outlook for 2025, supported by high demand for its technology-led advisory services and recent strategic acquisitions, such as the Hypothesis Group, which bolstered its capabilities in the US market.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.